Variant position: 353 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 514 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human IVVITTKGEAICMAIALMTT AVISTCDHGIVAKIKRVIMER
Mouse IVVITTKGEAICMAIALMTT AVISTCDHGIVAKIKRVIMER
Rat VVVITTKGEAVCVAIALMTT AVISTCDHGVVAKIKRVIMER
Chicken IVVITTKGEAICLAIALMTT AVISTCDHGVVAKIKRVIMER
Caenorhabditis elegans IVIMSTKGEAICIAIAQMNT STIASVDHGVVAKSKRVIMER
Drosophila IVICTTKGEAICLAIALMTT ATMASCDHGVVAKIKRVIMER
Slime mold VVLITTKGEAIAIGIAQMTT ASMATCDHGVVATIKRVIMDR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 514 H/ACA ribonucleoprotein complex subunit DKC1
296 – 371 PUA
353 – 353 A -> R. Increases interaction with SHQ1.
X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.
Knight S.W.; Heiss N.S.; Vulliamy T.J.; Greschner S.; Stavrides G.; Pai G.S.; Lestringant G.; Varma N.; Mason P.J.; Dokal I.; Poustka A.;
Am. J. Hum. Genet. 65:50-58(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS DKCX VAL-2; GLU-39; LYS-41; THR-65; ALA-66; VAL-321; ILE-350; THR-350; VAL-353 AND ARG-402;
Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita.
Grozdanov P.N.; Fernandez-Fuentes N.; Fiser A.; Meier U.T.;
Hum. Mol. Genet. 18:4546-4551(2009)
Cited for: INTERACTION WITH SHQ1; CHARACTERIZATION OF VARIANTS DKCX ALA-66; ILE-350; THR-350 AND VAL-353; CHARACTERIZATION OF VARIANTS HHS MET-49 AND GLY-121; MUTAGENESIS OF ALA-353;
Identification of a novel mutation and a de novo mutation in DKC1 in two Chinese pedigrees with Dyskeratosis congenita.
Ding Y.G.; Zhu T.S.; Jiang W.; Yang Y.; Bu D.F.; Tu P.; Zhu X.J.; Wang B.X.;
J. Invest. Dermatol. 123:470-473(2004)
Cited for: VARIANTS DKCX VAL-353 AND LEU-409;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.